Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
about
Downregulation and growth inhibitory role of FHL1 in lung cancerTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsGenetic susceptibility to lung cancer--light at the end of the tunnel?Alternative splicing for diseases, cancers, drugs, and databasesGenomic impact of cigarette smoke, with application to three smoking-related diseasesCIViC databaseCyclin D as a therapeutic target in cancerF-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferationRole of cell cycle regulators in lung carcinogenesisFBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrestF-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrestCyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesisA Ribonuclease Isolated from Wild Ganoderma Lucidum Suppressed Autophagy and Triggered Apoptosis in Colorectal Cancer CellsFluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cellsProteomic changes resulting from gene copy number variations in cancer cellsCurcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cellsCombined α-tocopherol and ascorbic acid protects against smoke-induced lung squamous metaplasia in ferrets.Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest.Consequence of the tumor-associated conversion to cyclin D1bEmerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators.Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas.Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activationModulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells.Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.
P2860
Q24307767-4C8CCE5B-7690-4037-9973-E708BD586E20Q26827580-FF86E8F0-617A-4D9E-A4E6-F9683C046468Q26852320-9CDA4FFF-E8B9-4B40-A9E6-18FD1EB1D37EQ26852848-2B4A6546-8542-4E36-BF32-BDFC15AD7389Q27027763-2CCA8733-8DCD-4BEC-87CA-F53BD7AD74BCQ27612411-99022904-9B2C-4867-97E4-73392EDAC983Q28242623-3DBA7ACC-9DC4-4965-A2BE-5FBA70CAA12FQ28383185-26A1E7F3-A1B1-4B5B-ABED-6518206289BBQ28394676-0FE67864-78A3-42DE-9D04-1185D2CFD31DQ28396015-E2FAF519-6133-4E1F-A908-EC75F94BA846Q28396057-50A17037-4295-43A6-BC5A-4CC4FE98EC5DQ28749707-E70E988D-DF2A-4E58-8531-03BD19151A0AQ28829188-31BD9404-553A-44C1-8CE3-29FCAA34CA19Q30419853-213A6D81-9E1F-4395-A004-7A5D61455B4EQ33496761-47395815-0817-4797-9355-E7B7C2B85F6EQ33686899-C882EFA6-5A23-4248-BE03-E198C604DFD1Q34000044-2686C6EB-99C1-4AE5-8B64-05265C95266CQ34516556-C76900CF-2BA0-42D1-A43B-744D2E2D89CDQ34575813-B519E2E6-B9AE-429D-829F-F1478118005FQ35088400-8051597A-5F8C-463E-8AB4-40B3607F9DC0Q35284709-216DC989-9D25-4B02-84AE-99C66B11AAA4Q35561919-F5398186-2275-4DC3-8267-98D560705A81Q35584127-0AF0218E-6941-4384-B661-C34171019441Q35625543-93503451-5567-4343-A815-ECC65B98F3C2Q35644000-F97E1A4C-791D-4B5C-84FF-2131E99AF0D4Q35804007-6B08BE32-A37F-41A1-A30E-7153F56E4820Q35822584-0FADC93F-E00B-4E19-9685-BE88D9306D4BQ36063833-3ACF4B1C-36D8-4D00-B1C4-AA156AFC0F2EQ36067911-1BF99EBA-6DF6-48A1-B9B4-AE7FD66DC0FDQ36169254-0C45FF84-9E55-4518-A70F-A01C5039FDEBQ36299710-3082EEDB-9F87-472C-A1BD-B71FA28D787AQ36545481-C0378F8B-27B6-435F-AC68-A21A132E60F2Q36661312-C0AE660C-EE54-48F6-946F-03980C9F3C94Q36946799-E6AC3F6D-2A50-4490-976A-7A4C0D54ABF9Q37297595-0A6ECA15-5D9F-4AFF-B569-2A3F00BE53F9Q37392616-476A5224-FEA0-4D69-A599-4253689E02F3Q37399532-ED5B91D3-E21A-41EE-80A2-4EF7636DD380Q37509502-671FA045-80F4-4234-8D2C-16F092775621Q37588369-B93C39F9-70A8-47DB-B846-7A51B8195C2AQ37773234-3C441623-85BA-47CD-A2BC-D426BB0224C6
P2860
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@ast
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@en
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@nl
type
label
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@ast
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@en
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@nl
prefLabel
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@ast
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@en
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@nl
P2093
P3181
P1433
P1476
Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
@en
P2093
Daniel C Betticher
Daniel Ratschiller
Jim Heighway
Mathias Gugger
Oliver Gautschi
P3181
P356
10.1016/J.LUNGCAN.2006.09.024
P407
P577
2007-01-01T00:00:00Z